Delivery Order SPE2DB22D2211-SPE2DB25FRYLH
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,743.34 for Valtoco 10 mg nasal sprays, a medication used in emergency seizure management. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a $1,760.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for Valtoco 10 mg nasal sprays, with completion scheduled for November 17, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on October 23, 2025, with a ceiling value of $1,823.55 and firm fixed pricing. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by October 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, valued at $2,252.20 under a firm fixed-price contract structure. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a $2,711.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 21, 2025, with completion targeted for August 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.21 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on November 12, 2025, with completion expected by November 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $2,633.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of October 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor contract running through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,197.63 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger contract vehicle with the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYLHDelivery Order
The Defense Logistics Agency awarded a $1,801.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Valtoco is an emergency rescue medication indicated for the treatment of acute repetitive seizure episodes in patients with epilepsy. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies comprehensive medical commodities to support military healthcare programs. The company's substantial IDC with DLA enables it to deliver a broad portfolio of pharmaceutical products, medical devices, vaccines, and specialized healthcare supplies across multiple therapeutic domains to defense and veteran healthcare systems. This delivery order exemplifies the company's role as a key supplier within the Defense Health Agency's pharmaceutical supply chain and demonstrates the operational flexibility of the larger prime vendor contract vehicle in fulfilling specific medical supply requirements across the federal sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/4/25 |